Fetal thyrotoxicosis in utero. 1979

J Serup, and S Petersen

A case of fetal thyrotoxicosis in utero in a boy with familial predisposition to thyrotoxicosis is reported. At 26 weeks of gestation fetal hyperkinesia and fetal tachycardia developed. This was preceded by a significant pathologic increase in long-acting thyroid stimulator (LATS) in the mother. The fetal hyperkinesia and tachycardia were considered to be signs of fetal thyrotoxicosis, possibly induced by placentally transferred LATS. The fetal thyrotoxicosis responded well to propylthiouracil given to the mother. After birth the boy developed slight signs of neonatal thyrotoxicosis although his serum thyroxine values increased analogous to those of his elder sister, who had presented classical neonatal thyrotoxicosis.

UI MeSH Term Description Entries
D006980 Hyperthyroidism Hypersecretion of THYROID HORMONES from the THYROID GLAND. Elevated levels of thyroid hormones increase BASAL METABOLIC RATE. Hyperthyroid,Primary Hyperthyroidism,Hyperthyroidism, Primary,Hyperthyroids
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008135 Long-Acting Thyroid Stimulator An immunoglobulin G, often found in the blood of hyperthyroid individuals. It stimulates the thyroid for a longer duration than does thyrotoxin and may cause hyperthyroidism in newborns due to placental transmission. LATS,Thyroid Stimulating Hormone Receptor Autoantibodies,Thyroid Stimulating Hormone Receptor Autoantibody,Thyroid Stimulator, Long-Acting,Thyrotropin Receptor Antibodies,Thyrotropin Receptor Antibody,Thyrotropin Receptor Autoantibodies,Thyrotropin Receptor Autoantibody,Antibody, Thyrotropin Receptor,Autoantibody, Thyrotropin Receptor,Long Acting Thyroid Stimulator,Receptor Antibody, Thyrotropin,Receptor Autoantibody, Thyrotropin,Thyroid Stimulator, Long Acting
D008297 Male Males
D008431 Maternal-Fetal Exchange Exchange of substances between the maternal blood and the fetal blood at the PLACENTA via PLACENTAL CIRCULATION. The placental barrier excludes microbial or viral transmission. Transplacental Exposure,Exchange, Maternal-Fetal,Exposure, Transplacental,Maternal Fetal Exchange
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011441 Propylthiouracil A thiourea antithyroid agent. Propythiouracil inhibits the synthesis of thyroxine and inhibits the peripheral conversion of throxine to tri-iodothyronine. It is used in the treatment of hyperthyroidism. (From Martindale, The Extra Pharmacopeoia, 30th ed, p534) 6-Propyl-2-Thiouracil,6 Propyl 2 Thiouracil
D005260 Female Females
D005315 Fetal Diseases Pathophysiological conditions of the FETUS in the UTERUS. Some fetal diseases may be treated with FETAL THERAPIES. Embryopathies,Disease, Fetal,Diseases, Fetal,Embryopathy,Fetal Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J Serup, and S Petersen
December 2014, Journal de gynecologie, obstetrique et biologie de la reproduction,
J Serup, and S Petersen
April 1984, Soins. Gynecologie, obstetrique, puericulture, pediatrie,
J Serup, and S Petersen
October 1965, La Revue du praticien,
J Serup, and S Petersen
January 1951, Strasbourg medical,
J Serup, and S Petersen
January 1956, Obstetricia y ginecologia latino-americanas,
J Serup, and S Petersen
January 1967, Bulletin de la Federation des societes de gynecologie et dobstetrique de langue francaise,
J Serup, and S Petersen
November 1986, Revue francaise de gynecologie et d'obstetrique,
J Serup, and S Petersen
December 1963, American journal of obstetrics and gynecology,
J Serup, and S Petersen
April 1977, Developmental medicine and child neurology,
Copied contents to your clipboard!